Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kermani

Showing results (21-30 of 119) with videos related to

Pageof 12
Sort By:
Med (New York, N.Y.)|June 14, 2025
JAKing down glucocorticoids in giant cell arteritisTanaz A Kermani, Kenneth J Warrington
Eye (London, England)|March 9, 2013
Comment on: How common is inflammatory marker-negative disease in giant cell arteritis?T A Kermani, K J Warrington
Therapeutic Advances in Musculoskeletal Disease|February 4, 2014
Advances and challenges in the diagnosis and treatment of polymyalgia rheumaticaTanaz A Kermani, Kenneth J Warrington
Current Neurology and Neuroscience Reports|December 30, 2011
Recent advances in diagnostic strategies for giant cell arteritisTanaz A Kermani, Kenneth J Warrington
Digestive Diseases and Sciences|December 16, 2000
Gastrointestinal bleeding in a woman with pulmonary tuberculosisS Basaria, M Croitoru, A Kermani
Methods in Molecular Biology (Clifton, N.J.)|March 1, 2020
Membrane Protein Production in Escherichia coliBenjamin C McIlwain, Ali A Kermani
Arthritis Care & Research|March 4, 2024
Improving on Intuition: Assessing Disease Activity in Takayasu ArteritisSharon A Chung, Tanaz A Kermani
Best Practice & Research. Clinical Rheumatology|June 16, 2023
Recent advances in the treatment of giant cell arteritisJason M Springer, Tanaz A Kermani
Clinical and Experimental Rheumatology|April 22, 2026
Significance of positive rheumatoid factor in ANCA-associated vasculitisTanaz A Kermani, Kenneth J Warrington
Therapeutic Advances in Musculoskeletal Disease|August 8, 2012
Malignancy risk in vasculitisTanaz A Kermani, Kenneth J Warrington, Shreyasee Amin
Pageof 12

Showing results (21-30 of 119) with videos related to

Sort By:
Pageof 12
Med (New York, N.Y.)|June 14, 2025
JAKing down glucocorticoids in giant cell arteritisTanaz A Kermani, Kenneth J Warrington
Eye (London, England)|March 9, 2013
Comment on: How common is inflammatory marker-negative disease in giant cell arteritis?T A Kermani, K J Warrington
Therapeutic Advances in Musculoskeletal Disease|February 4, 2014
Advances and challenges in the diagnosis and treatment of polymyalgia rheumaticaTanaz A Kermani, Kenneth J Warrington
Current Neurology and Neuroscience Reports|December 30, 2011
Recent advances in diagnostic strategies for giant cell arteritisTanaz A Kermani, Kenneth J Warrington
Digestive Diseases and Sciences|December 16, 2000
Gastrointestinal bleeding in a woman with pulmonary tuberculosisS Basaria, M Croitoru, A Kermani
Methods in Molecular Biology (Clifton, N.J.)|March 1, 2020
Membrane Protein Production in Escherichia coliBenjamin C McIlwain, Ali A Kermani
Arthritis Care & Research|March 4, 2024
Improving on Intuition: Assessing Disease Activity in Takayasu ArteritisSharon A Chung, Tanaz A Kermani
Best Practice & Research. Clinical Rheumatology|June 16, 2023
Recent advances in the treatment of giant cell arteritisJason M Springer, Tanaz A Kermani
Clinical and Experimental Rheumatology|April 22, 2026
Significance of positive rheumatoid factor in ANCA-associated vasculitisTanaz A Kermani, Kenneth J Warrington
Therapeutic Advances in Musculoskeletal Disease|August 8, 2012
Malignancy risk in vasculitisTanaz A Kermani, Kenneth J Warrington, Shreyasee Amin
Pageof 12